HBV DNA polymerase upregulates the transcription of PD-L1 and suppresses T cell activity in hepatocellular carcinoma

被引：0
|
作者：
Yan Jia
Jianing Zhao
Chunqing Wang
Jing Meng
Liqing Zhao
Hongwei Yang
Xiaoqing Zhao
机构：
[1] Tianjin Hospital,Department of Laboratory Medicine
[2] The Fourth Hospital of Hebei Medical University,Department of Pathology
[3] The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital,Department of Clinical Laboratory Medicine
[4] Shandong Medicine and Health Key Laboratory of Laboratory Medicine,Department of Clinical Laboratory
[5] The Second Hospital,Department of Pediatrics
[6] Cheeloo College of Medicine,undefined
[7] Shandong University,undefined
[8] Zaozhuang Municipal Hospital,undefined
来源：
Journal of Translational Medicine | / 22卷
关键词：
Hepatocellular carcinoma; T cell dysfunction; HBV DNA polymerase; PD-L1; PARP1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] POTENTIAL AS BIOMARKERS OF SOLUBLE PD-1 AND PD-L1 IN HEPATOCELLULAR CARCINOMA
    Kanzaki, Hiroaki
    Chiba, Tetsuhiro
    Kato, Naoya
    HEPATOLOGY, 2019, 70 : 1218A - 1218A
  • [22] GOLM1 UPREGULATES EXPRESSION OF PD-L1 THROUGH EGFR/STAT3 PATHWAY IN HEPATOCELLULAR CARCINOMA
    Yen, Jiuliang
    Zhou, Binghai
    Guo, Lei
    Zhang, Bo
    Liu, Shuang
    Zhang, Wentao
    Yu, Mincheng
    Chen, Zheng
    Xu, Yongfeng
    Xiao, Yongsheng
    Li, Hui
    Ye, Qinghai
    HEPATOLOGY, 2020, 72 : 664A - 664A
  • [23] PD-1/PD-L1 blockade can improve the HBV-specific T cell function in chronic hbv infection
    Fisicaro, P.
    Boni, C.
    Valdatta, C.
    Bertoletti, A.
    Schivazappa, S.
    Giuberti, T.
    Cavalli, A.
    Missale, G.
    Ferrari, C.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S56 - S56
  • [24] MYELOID DIFFERENTIATION FACTOR 88 REGULATES EXPRESSION OF PD-L1 AND VEGF IN HBV RELATED HEPATOCELLULAR CARCINOMA
    Song, Myeong Jun
    HEPATOLOGY, 2022, 76 : S1361 - S1362
  • [25] PD-L1 in oral squamous cell carcinoma
    Ragos, Vasileios
    Mastronikolis, Nicholas S.
    Tsiambas, Evangelos
    Fotiades, Panagiotis P.
    JOURNAL OF BUON, 2018, 23 (03): : 835 - 836
  • [26] Cell fusion upregulates PD-L1 expression for evasion from immunosurveillance
    Youichi Tajima
    Futoshi Shibasaki
    Hisao Masai
    Cancer Gene Therapy, 2024, 31 : 158 - 173
  • [27] DEAD-box helicase 1 inhibited CD8+ T cell antitumor activity by inducing PD-L1 expression in hepatocellular carcinoma
    Liu, Junhao
    Yang, Ti
    Luo, Yurong
    Ma, Zengxin
    Yu, Zhitao
    Zhang, Lei
    Liu, Gai
    Wen, Jianfan
    Lu, Guankun
    Zhang, Guowei
    Zhao, Yujun
    Luo, Wang
    Li, Yanan
    Yang, Nengjia
    Zhou, Jiawei
    Lu, Yuhui
    Chen, Siliang
    Zeng, Xiancheng
    CANCER SCIENCE, 2024, 115 (03) : 763 - 776
  • [28] Combination of tumor-associated regulatory T cell deletion and PD-1/PD-L1 blockade: A promising immunotherapy for hepatocellular carcinoma?
    Hua-Yu Yang
    Le-Jia Sun
    Yi-Lei Mao
    Hepatobiliary & Pancreatic Diseases International, 2018, 17 (02) : 93 - 94
  • [29] Combination of tumor-associated regulatory T cell deletion and PD-1/PD-L1 blockade: A promising immunotherapy for hepatocellular carcinoma?
    Yang, Hua-Yu
    Sun, Le-Jia
    Mao, Yi-Lei
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2018, 17 (02) : 93 - 94
  • [30] Cell fusion upregulates PD-L1 expression for evasion from immunosurveillance
    Tajima, Youichi
    Shibasaki, Futoshi
    Masai, Hisao
    CANCER GENE THERAPY, 2024, 31 (01) : 158 - 173
12345